Headquartered in Seoul, South Korea, LOTTE BIOLOGICS was founded in 2022 with a mission to deliver therapies that contribute to a healthier world.
At the Syracuse Bio Campus in New York, LOTTE BIOLOGICS provides high-quality GMP manufacturing services for drug substances. The facility offers a total production capacity of 40,000L, supported by eight 5,000L stainless steel bioreactors. Additionally, the campus includes extensive analytical QC testing laboratories and warehouse facilities that have received over 62 regulatory approvals from agencies worldwide. LOTTE BIOLOGICS is also advancing into a new area of expertise with Antibody-Drug Conjugates (ADCs) services. With over $100 million invested in ADC modalities, including both drug substance and conjugation capabilities on-site, we offer a seamless, end-to-end service from drug substance manufacturing to conjugation.
Looking ahead, LOTTE BIOLOGICS is constructing three advanced bio plants in Songdo, South Korea. With construction of the first plant already underway and expected to be operational by 2027, each facility will feature eight 15,000L stainless steel bioreactors for large-scale commercial production, along with multiple 3,000L bioreactors to meet clinical production needs. Collectively, these plants will provide a manufacturing volume exceeding 360,000L in bioreactor capacity.
Through our commitment to delivering innovative medicines to patients worldwide, LOTTE BIOLOGICS aims to become a top-tier global CDMO company in the biopharmaceutical industry.
Company Details
- Employees
- 517
- Founded
- -
- Address
- 300, Olympic-Ro, Songpa-Gu, Seoul,korea, Republic Of
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- HQ
- Seoul
Lotte Biologics Questions
Lotte Biologics's website is https://www.lottebiologics.com/en
Lotte Biologics's LinkedIn profile is https://www.linkedin.com/company/lotte-biologics
Lotte Biologics has
517 employees.
View email and phone details for 517
employees at Lotte Biologics.
Lotte Biologics's industry is
Pharmaceutical Manufacturing
Lotte Biologics's top competitors are
Lg Chem,
Yuhan Corporation,
Samsung Bioepis,
Samsung Biologics,
Daewoong Pharmaceutical,
Celltrion Inc,
Sk Bioscience,
Hanmi Pharmaceuticals,
Gc Biopharma (Gc녹십자),
Sk Biopharmaceuticals.
Lotte Biologics's categories are Pharmaceutical Manufacturing
Lotte Biologics's founding year is 2022
